Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children

Lynne M. Mofenson, John Moye, James Korelitz, James Bethel, Ronald Hirschhorn, Robert Nugent, A. Willoughby, H. W. Berendes, J. G. Rigau-Perez, Sumner Yaffe, K. Shah, J. Chow, P. Edelson, D. Sanders, V. Bonagura, D. Valacer, W. Henley, M. Bamji, A. Gupta, K. I. LiE. J. Abrams, M. Frere, S. Fikrig, S. S. Bakshi, S. Pahwa, K. Krasinski, J. Pitt, L. Bernstein, A. Rubinstein, G. Johnson, E. R. Cooper, L. Frenkel, S. Gaur, H. W. Lischner, S. A. Raphael, J. P. Johnson, T. Rakusan, S. Nesheim, A. Nahmias, H. Keyserling, R. Yogev, E. Chadwick, K. Rich, W. T. Shearer, I. C. Guerra-Hanson, A. Petru, C. Diaz, J. L. Colon Santini, E. Jimenez, D. Garcia-Trias, C. Acantilado, S. Durako, C. Jordan Nesel, K. Rust, R. Schwartz

Research output: Contribution to journalArticlepeer-review

34 Scopus citations

Fingerprint

Dive into the research topics of 'Crossover of placebo patients to intravenous immunoglobulin confirms efficacy for prophylaxis of bacterial infections and reduction of hospitalizations in human immunodeficiency virus-infected children'. Together they form a unique fingerprint.

Medicine & Life Sciences